Ahmed Bennis/X
Aug 30, 2026, 16:06
Ahmed Bennis: Highly Individualized Anticoagulation Decision-Making Stratified by eGFR
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared a post on X:
“ESC Congress 2026 Munich.
Highly individualized decision-making, stratified by eGFR:
- eGFR 30–59: DOAC preferred over LMWH or VKA (Class I) for both VTE and AF.
- eGFR 15–29: Factor Xa inhibitor preferred over VKA (Class IIa/IIb).
- Dialysis or eGFR below 15: VKA or low-dose apixaban (Class IIb).”
Other posts featuring Ahmed Bennis on Hemostasis Today.
-
Oct 16, 2026, 18:12Adil Nawaz: Extended Dual Antiplatelet Therapy After Coronary Stenting
-
Oct 16, 2026, 17:50Elad Asher։ STORM-PE Shows Functional Benefits of Thrombectomy
-
Oct 16, 2026, 17:32Shruthi Narayan: STORM-PE and STRIKE-PE Studies Advance Understanding of Recovery After Pulmonary Embolism
-
Oct 16, 2026, 17:22Wolfgang Miesbach։ What a Near-Perfect FISH Score Fails to See
-
Oct 16, 2026, 17:06Troels Wienecke: Connecting Myeloproliferative Disease and Ischemic Stroke
-
Oct 16, 2026, 17:03Only 5 Days Left to Submit Your Research for EAHAD 2027
-
Oct 16, 2026, 16:48Abdul Rahman: Reticulocyte Count and Bone Marrow Activity
-
Oct 16, 2026, 16:44DOAC Adherence in Stroke Patients With Atrial Fibrillation – International Journal of Stroke
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand